TradingAgents AISign inGet started
All stock profiles
ALVONASDAQHealthcare

ALVOTECH

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$4.65

-4.91%

Alpha Vantage · 10/30/2026

Industry: Drug Manufacturers - Specialty & GenericCategory: ADR Common Stock Primary ClassCurrency: USDNews: 0 recent
Analyze ALVO free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-17.3%

3 months

+22.7%

6 months

+34.4%

1 year

-40.7%

Year to date

-9.4%

52-week range

$3.00 – $7.84

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$1.66B

P/E

-9.2

P/B

-8.7

P/S

3.4

Revenue

$494.61M

Net income

-$179.59M

Diluted EPS

-0.61

Gross margin

60.70%

Net margin

-36.30%

Return on equity

76.80%

Total debt

$1.45B

Cash

$142.75M

Free cash flow

-$139.85M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$105.91M-$66.82M50.70%-63.10%-$10.42M
Mar 31, 2026$105.95M$1.03M56.50%1.00%-$32.39M
Dec 31, 2025$168.9M-$108.55M63.70%-64.30%-$36.81M
Sep 30, 2025$113.86M-$5.25M69.30%-4.60%-$60.24M
Jun 30, 2025$173.34M$32.04M57.40%18.50%$45.53M
Mar 31, 2025$132.81M$109.68M50.70%82.60%-$5.8M
Dec 31, 2024$153.34M-$66.97M47.60%-43.70%-$68.49M
Sep 30, 2024$102.99M-$11.39M61.30%-11.10%-$74.79M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ALVO news

All market news

No ticker-linked stories are in the current archive.